文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新加坡SARS-CoV-2感染患者的流行病学特征与临床病程

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
PubMed 文献 · JAMA · 2020-01-01
一句话结论新加坡首批18例SARS-CoV-2感染患者多表现为轻症上呼吸道感染,部分需氧疗,洛匹那韦-利托那韦经验性治疗后转归不一。

该研究为描述性病例系列,报告2020年1月23日至2月3日新加坡4家医院确诊的首18例SARS-CoV-2感染患者(中位年龄47岁,50%女性)。临床表现以上呼吸道感染为主(12例,67%),鼻咽部病毒排出持续7天及以上者15例(83%)。6例(33%)需补充氧气,其中2例需重症监护,无死亡。5例需氧疗者接受洛匹那韦-利托那韦治疗,3例3天内退热且氧需求下降,2例进展为进行性呼吸衰竭;4例出现恶心、呕吐和/或腹泻,3例肝功能异常。

要点

  • 18例确诊患者中12例(67%)表现为上呼吸道感染,6例(33%)需补充氧气,2例需重症监护,无死亡。
  • 鼻咽部病毒排出持续7天及以上者15例(83%),粪便PCR阳性4/8(50%),血液PCR阳性1/12(8%),尿液未检出。
  • 5例需氧疗者接受洛匹那韦-利托那韦治疗,3例3天内退热且氧需求下降,2例进展为进行性呼吸衰竭。
  • 洛匹那韦-利托那韦治疗者中4例出现恶心、呕吐和/或腹泻,3例出现肝功能检查异常。

适用人群与场景

  • 2020年1月23日至2月3日在新加坡4家医院住院、经聚合酶链反应(PCR)确诊SARS-CoV-2感染的成年患者(中位年龄47岁,9例女性)。

处置流程与药物剂量

  • 5例需补充氧气的患者接受洛匹那韦-利托那韦经验性治疗;原文未写明剂量、给药途径、频次或疗程。

研究设计与关键结果

  • 描述性病例系列,纳入新加坡4家医院首批18例PCR确诊SARS-CoV-2感染住院患者(中位年龄47岁,9例女性),随访截止2020年2月25日。
  • 临床表现:上呼吸道感染12例(67%);鼻咽部病毒排出持续7天及以上15例(83%)。
  • 6例(33%)需补充氧气,其中2例需重症监护;无死亡。
  • 病毒PCR检出:粪便4/8(50%),血液1/12(8%),尿液未检出。
  • 5例需氧疗者接受洛匹那韦-利托那韦治疗:3例3天内退热且氧需求下降,2例进展为进行性呼吸衰竭;4例出现恶心、呕吐和/或腹泻,3例肝功能检查异常。

证据类型、等级与局限

  • 证据类型:描述性病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 新加坡首批18例患者中多数表现为轻症上呼吸道感染,但部分需补充氧气并出现不同临床转归;洛匹那韦-利托那韦经验性治疗后部分患者退热且氧需求下降,部分进展为呼吸衰竭,且常见胃肠道不良反应和肝功能异常。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China.

OBJECTIVE: To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management.

DESIGN, SETTING, AND PARTICIPANTS: Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020.

EXPOSURES: Confirmed SARS-CoV-2 infection.

MAIN OUTCOMES AND MEASURES: Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir.

RESULTS: Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.

CONCLUSIONS AND RELEVANCE: Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020. PMID: 32125362. doi:10.1001/jama.2020.3204

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。